Accreditation self-declared (DAkkS)
Berlin-based quality assurance organisation for pathology that runs interlaboratory tests (Ringversuche) in immunohistochemistry, in-situ hybridisation and molecular pathology for predictive tumour biomarkers, using FFPE tissue, genomic DNA and cfDNA test sets.
Mammakarzinom: ER, PR, Ki-67, HER2 (IHC)
Mammakarzinom: HER2 (ISH)
HER2-ultralow Mammakarzinom (IHC)
dMMR (IHC)
HER2 Magenkarzinom (IHC / ISH)
Lung Cancer Related Markers – ALK (IHC / ISH), ROS1 (IHC)
Lung Cancer Related Markers – Mutations: EGFR, KRAS, BRAF (MolPath)
RAS Mutationsanalyse (MolPath)
BRCA1/2 Mutation Analysis (MolPath)
PIK3CA Mutation Analysis (MolPath)
Mikrosatelliteninstabilität-PCR (MolPath)
MGMT Promoter Methylation Analysis (MolPath)
KlonML B-Zell / T-Zell Lymphome (MolPath)
HPV HNSCC (MolPath) and p16 HNSCC (IHC)
ESR1 Mutation Analysis in Breast Cancer (Liquid Biopsy)
| Scheme | Testing fields | Sample type | Analytes | Rounds/yr | Link |
|---|---|---|---|---|---|
| Mammakarzinom: ER, PR, Ki-67, HER2 (IHC) |
| FFPE tissue | ER, PR, Ki-67, HER2 | — | Scheme page for Mammakarzinom: ER, PR, Ki-67, HER2 (IHC) (opens in a new tab) |
| Mammakarzinom: HER2 (ISH) |
| FFPE tissue | HER2 | — | Scheme page for Mammakarzinom: HER2 (ISH) (opens in a new tab) |
| HER2-ultralow Mammakarzinom (IHC) |
| FFPE tissue | — | — | Scheme page for HER2-ultralow Mammakarzinom (IHC) (opens in a new tab) |
| dMMR (IHC) |
| FFPE tissue | — | — | Scheme page for dMMR (IHC) (opens in a new tab) |
| HER2 Magenkarzinom (IHC / ISH) |
| FFPE tissue | — | — | Scheme page for HER2 Magenkarzinom (IHC / ISH) (opens in a new tab) |
| Lung Cancer Related Markers – ALK (IHC / ISH), ROS1 (IHC) |
| FFPE tissue | ALK, ROS1 | — | Scheme page for Lung Cancer Related Markers – ALK (IHC / ISH), ROS1 (IHC) (opens in a new tab) |
| Lung Cancer Related Markers – Mutations: EGFR, KRAS, BRAF (MolPath) |
| — | EGFR, KRAS, BRAF | — | Scheme page for Lung Cancer Related Markers – Mutations: EGFR, KRAS, BRAF (MolPath) (opens in a new tab) |
| RAS Mutationsanalyse (MolPath) |
| — | — | — | Scheme page for RAS Mutationsanalyse (MolPath) (opens in a new tab) |
| BRCA1/2 Mutation Analysis (MolPath) |
| — | — | — | Scheme page for BRCA1/2 Mutation Analysis (MolPath) (opens in a new tab) |
| PIK3CA Mutation Analysis (MolPath) |
| — | — | — | Scheme page for PIK3CA Mutation Analysis (MolPath) (opens in a new tab) |
| Mikrosatelliteninstabilität-PCR (MolPath) |
| — | — | — | Scheme page for Mikrosatelliteninstabilität-PCR (MolPath) (opens in a new tab) |
| MGMT Promoter Methylation Analysis (MolPath) |
| — | — | — | Scheme page for MGMT Promoter Methylation Analysis (MolPath) (opens in a new tab) |
| KlonML B-Zell / T-Zell Lymphome (MolPath) |
| — | — | — | Scheme page for KlonML B-Zell / T-Zell Lymphome (MolPath) (opens in a new tab) |
| HPV HNSCC (MolPath) and p16 HNSCC (IHC) |
| — | — | — | Scheme page for HPV HNSCC (MolPath) and p16 HNSCC (IHC) (opens in a new tab) |
| ESR1 Mutation Analysis in Breast Cancer (Liquid Biopsy) |
| cfDNA | — | — | Scheme page for ESR1 Mutation Analysis in Breast Cancer (Liquid Biopsy) (opens in a new tab) |
No reviews yet. If your lab has taken part in QuIP – Qualitätssicherungs-Initiative Pathologie QuIP GmbH's schemes, you can rate it.
Ratings come from reviewers who confirmed their email address, and every review is checked by EqasOnline before it appears. An average is shown once a provider has 3 reviews.
Run this scheme? Ask your participating labs to rate you:
Self-declared: stated by the provider and not yet verified by EqasOnline.
Compiled from QuIP – Qualitätssicherungs-Initiative Pathologie QuIP GmbH's own published information or sent in by the provider, and reviewed by EqasOnline. Check scheme details, fees and dates with the provider before you enrol. 15 schemes listed here.
Last updated 1 Nov 2026.
Is this your organisation, or is something out of date? Update this listing.
Other providers listing schemes in the same testing fields, those in Germany first.
Heidelberg, GermanyInternational participants
Schemes: Clinical ChemistryBlood Gas and ElectrolytesCardiac Marker POCT
24 schemes
Accreditation self-declared (DAkkS)Düsseldorf, GermanyInternational participants
Schemes: Clinical Chemistry - Conventional AnalysisCapillary Zone ElectrophoresisLipids/Lipoproteins
25 schemes
Accreditation self-declared (DAkkS)Bonn, GermanyInternational participants
Schemes: Clinical chemical analytes in serum "wet chemistry" (Serum)Clinical chemical analytes in urine (Urine)Glucose (wet chemistry)
22 schemes
Accreditation self-declared (DAkkS)France
Schemes: IHC HER2 (sein)IHC PD-L1 (poumon)IHC ALK (poumon)
13 schemes
Leuven, BelgiumInternational participants
Schemes: Cystic fibrosis EQA scheme (CF2026 / CF2027, with the European CF Network)EuroClonality IG/TR schemeGen&Tiss somatic tumour testing schemes (tissue NGS, targeted gene testing, ovarian BRCA1/2 with HRD, fusion transcripts, ctDNA)
3 schemes
Accreditation self-declared (BELAC)LuxembourgInternational participants
Schemes: DNA quantification and purityDNA integrityRNA integrity
5 schemes